Thoracoabdominal Aortic Aneurysms

N/ANot Yet RecruitingNCT06267573

Assiut University100 enrolled

Overview

Evaluation of the effectiveness of the different modalities for treatment of thoracoabdominal aortic aneurysms. FEVAR and BEVAR devices are widely used now due to its feasability and wide range of use . We aim to evaluate the effectiveness of these new devices in the management of TAAA

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Thoracoabdominal Aortic Aneurysm

Interventions

Fenestrated and branched endovascular devices for TAAADEVICE

Devices for TAAA

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * all adult consecutive patients presenting with TAAA larger than 5.5 cm Exclusion Criteria: * active infection Asymptomatic patients with small aneurysms Allergy to contrast agents

Outcomes

Primary Outcomes

Successful cannulation of the target vessels with complete in-line flow to target organs.

No ischemia

Time frame: Two years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.